FenbufenFenbufen
MedChemExpress (MCE)
HY-B1138
36330-85-5
CL-82204
99.33%
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Room temperature in continental US
may vary elsewhere.
Fenbufen (CL-82204) is an orally active non-steroidal anti-inflammatory drug (NSAID), with analgetic and antipyretic effects. Fenbufen has potent activity in a variety of animal model, including carageenin edema, UV erythema and adjuvant arthritis. Fenbufen has inhibitory activities against COX-1 and COX-2 with IC50s of 3.9 μM and 8.1 μM, respectively. Fenbufen is a caspases (caspase-1, 3, 4, 5, 9) inhibitor.
Fenbufen (100-500 μM) improves the viability of apoptotic THP-1 cells treated with 25 μM Nigericin (HY-127019)[5].
Fenbufenmay (1200 mg/kg
feed) does not cause gastric ulceration whilst inducing a near maximal inhibition of prostaglandin release in rats[6]. Fenbufenmay (1200 mg/kg
p.o.
diet
for 10 days) blocks the hypertrophy of the heart but not that of the skeletal muscles[6].
COX-1 3.9 μM (IC50) COX-2 8.1 μM (IC50) Caspase-1 4.4 μM (IC50) Caspase-3 1.2 μM (IC50) Caspase-4 0.57 μM (IC50) Caspase-5 0.87 μM (IC50) Caspase-9 0.76 μM (IC50)
| | | |
| | | | | |
[1]. A E Sloboda, et al. The pharmacological properties of fenbufen. A review. Arzneimittelforschung. 1980
30(4A):716-21. [Content Brief]
[2]. R G Child, et al. Fenbufen, a new anti-inflammatory analgesic: synthesis and structure-activity relationships of analogs, J Pharm Sci. 1977 Apr
66(4):466-76. [Content Brief]
[3]. A E Sloboda, et al. The pharmacology of fenbufen, 3-(4-biphenylylcarbonyl)propionic acid, and 4-biphenylacetic acid, interesting antiinflammatory-analgesic agents. Inflammation. 1976 Dec
1(4):415-38. [Content Brief]
[4]. Asif Husain, et al. Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agents. Eur J Med Chem . 2009 Sep
44(9):3798-804. [Content Brief]
[5]. Christina E Smith, et al. Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors. Cell Chem Biol. 2017 Mar 16
24(3):281-292. [Content Brief]
[6]. R M Palmer, et al. Effects of the cyclo-oxygenase inhibitor, fenbufen, on clenbuterol-induced hypertrophy of cardiac and skeletal muscle of rats. Br J Pharmacol. 1990 Dec
101(4):835-8. [Content Brief]